F Coste

571 total citations
34 papers, 379 citations indexed

About

F Coste is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, F Coste has authored 34 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in F Coste's work include Pulmonary Hypertension Research and Treatments (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Mitochondrial Function and Pathology (3 papers). F Coste is often cited by papers focused on Pulmonary Hypertension Research and Treatments (6 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers) and Mitochondrial Function and Pathology (3 papers). F Coste collaborates with scholars based in France, Switzerland and United States. F Coste's co-authors include Patrick Berger, Pierre‐Olivier Girodet, Roger Marthan, Gaël Dournes, François Laurent, Michel Montaudon, Cyril Reboul, François Picard, Claire Dromer and Élodie Blanchard and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

F Coste

27 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Coste France 13 139 100 77 53 40 34 379
Hisanaga Yagyu Japan 13 134 1.0× 77 0.8× 88 1.1× 93 1.8× 119 3.0× 37 481
B. Baudin France 12 63 0.5× 137 1.4× 89 1.2× 135 2.5× 40 1.0× 27 454
Shiro YAMADA Japan 12 51 0.4× 182 1.8× 67 0.9× 84 1.6× 76 1.9× 46 489
Chikahide Hori Japan 13 62 0.4× 78 0.8× 61 0.8× 29 0.5× 43 1.1× 36 403
D. Joseph France 9 77 0.6× 63 0.6× 219 2.8× 83 1.6× 52 1.3× 24 455
J. J. Weening Netherlands 6 34 0.2× 92 0.9× 33 0.4× 71 1.3× 44 1.1× 12 403
Pablo Saborío United States 11 126 0.9× 124 1.2× 39 0.5× 13 0.2× 40 1.0× 17 422
Gail L. Gossman United States 12 297 2.1× 65 0.7× 226 2.9× 21 0.4× 34 0.8× 15 604
Lorraine L. Thomas United States 10 85 0.6× 59 0.6× 144 1.9× 41 0.8× 95 2.4× 17 406
Alpay Çakmak Türkiye 13 50 0.4× 77 0.8× 47 0.6× 25 0.5× 59 1.5× 37 425

Countries citing papers authored by F Coste

Since Specialization
Citations

This map shows the geographic impact of F Coste's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Coste with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Coste more than expected).

Fields of papers citing papers by F Coste

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Coste. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Coste. The network helps show where F Coste may publish in the future.

Co-authorship network of co-authors of F Coste

This figure shows the co-authorship network connecting the top 25 collaborators of F Coste. A scholar is included among the top collaborators of F Coste based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Coste. F Coste is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dubois, Mathilde, F Coste, Guillaume Walther, et al.. (2024). Exercise training may reduce fragmented mitochondria in the ischemic-reperfused heart through DRP1. The Journal of General Physiology. 156(12).
2.
Dubois, Mathilde, Isabelle Bornard, F Coste, et al.. (2024). Hyperglycemia triggers RyR2-dependent alterations of mitochondrial calcium homeostasis in response to cardiac ischemia-reperfusion: Key role of DRP1 activation. Redox Biology. 70. 103044–103044. 17 indexed citations
3.
Cardouat, Guillaume, F Coste, Paul Robillard, et al.. (2022). Inflammation and Oxidative Stress Induce NGF Secretion by Pulmonary Arterial Cells through a TGF-β1-Dependent Mechanism. Cells. 11(18). 2795–2795. 6 indexed citations
4.
Coste, F, et al.. (2022). Hypoxémie : de la physiopathologie au diagnostic. Revue Médicale Suisse. 18(804). 2157–2161.
5.
Coste, F, et al.. (2020). Exercise training protects the heart against ischemia-reperfusion injury: A central role for mitochondria?. Free Radical Biology and Medicine. 152. 395–410. 20 indexed citations
6.
Dupin, Isabelle, Matthieu Thumerel, F Coste, et al.. (2019). Fibrocyte accumulation in the airway walls of COPD patients. European Respiratory Journal. 54(3). 1802173–1802173. 22 indexed citations
7.
Coste, F, Ilyès Benlala, Gaël Dournes, et al.. (2019). <p>Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension</p>. International Journal of COPD. Volume 14. 381–389. 10 indexed citations
8.
Coste, F, Ilyès Benlala, Gaël Dournes, et al.. (2019). <p>Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?</p>. International Journal of COPD. Volume 14. 2065–2079. 14 indexed citations
9.
10.
Coste, F, Gaël Dournes, Claire Dromer, et al.. (2016). CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax. 71(9). 830–837. 38 indexed citations
11.
Freund‐Michel, Véronique, Marcelina Cardoso Dos Santos, Christophe Guignabert, et al.. (2015). Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 192(3). 342–355. 21 indexed citations
12.
Coste, F, Arnaud Courtois, Christelle Guibert, et al.. (2015). Reversal of experimental severe pulmonary hypertension by NGF inhibition. Revue des Maladies Respiratoires. 32(3). 325–325.
13.
Dournes, Gaël, François Laurent, F Coste, et al.. (2014). Computed Tomographic Measurement of Airway Remodeling and Emphysema in Advanced Chronic Obstructive Pulmonary Disease. Correlation with Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 191(1). 63–70. 42 indexed citations
14.
Bressenot, Aude, Shabnam Pooya, Carine Bossenmeyer‐Pourié, et al.. (2012). Methyl donor deficiency affects small-intestinal differentiation and barrier function in rats. British Journal Of Nutrition. 109(4). 667–677. 43 indexed citations
15.
Chen, Min, Laurent Peyrin‐Biroulet, F Coste, et al.. (2010). Methyl deficient diet aggravates experimental colitis in rats. Journal of Cellular and Molecular Medicine. 15(11). 2486–2497. 31 indexed citations
16.
Coste, F, et al.. (2003). [Mechanism of action of hydrocortisone injected into the joints; therapeutic trial with a soluble ester of hydrocortisone (hemisuccinate)].. PubMed. 22(9-10). 657–64.
17.
Maroteaux, P, et al.. (1968). [Osteodysplasty (Melnick-Needles syndrome)].. PubMed. 76(15). 715–8. 10 indexed citations
18.
Amor, B, F Coste, & F Delbarre. (1967). [Demonstration, by cultures, of agents of the genus Bedsonia in joint fluid in cases of Fiessinger-Leroy-Reiter rheumatism].. PubMed. 264(10). 1365–7. 3 indexed citations
19.
Amor, B, et al.. (1965). [ON THE POSSIBLE VIRAL ORIGIN OF THE OCULO-URETHRO-SYNOVIAL SYNDROME].. PubMed. 73. 1825–30. 10 indexed citations
20.
Coste, F, et al.. (1960). [The treatment of inflammatory rheumatism by antimalarials (chloroquine and hydroxychloroquine)].. PubMed. 36. 999–1007. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hisanaga Yagyu Breakdown of academic impact, for papers by B. Baudin Breakdown of academic impact, for papers by Shiro YAMADA Breakdown of academic impact, for papers by Chikahide Hori Breakdown of academic impact, for papers by D. Joseph Breakdown of academic impact, for papers by J. J. Weening Breakdown of academic impact, for papers by Pablo Saborío Breakdown of academic impact, for papers by Gail L. Gossman Breakdown of academic impact, for papers by Lorraine L. Thomas Breakdown of academic impact, for papers by Alpay Çakmak
Rankless by CCL
2026